BioCentury | Mar 18, 2013
Clinical News

Zyngenia preclinical data

...In a mouse xenograft model of pancreatic cancer, Zyngenia's cetuximab-based bispecific zybody targeting EGFR and epidermal growth factor...
...in Japan where the 3 companies market the drug. Zyngenia Inc. , Gaithersburg, Md. Product: Cetuximab-based bispecific zybody...
Items per page:
1 - 1 of 1